Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 6:16 AM ET


Company Overview of Kolltan Pharmaceuticals, Inc.

Key Executives for Kolltan Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Gerald McMahon Ph.D.28 RelationshipsChief Executive Officer, President and Director60
Arthur G. Altschul Jr.38 RelationshipsCo-Founder and Chairman of the Board50
Joseph P. Schlessinger Ph.D.72 RelationshipsCo-Founder, Chairman of Scientific Advisory Board, Chief Scientist and Director70
Jane Pritchett V. Henderson 14 RelationshipsChief Financial & Business Officer and Senior Vice President49
Theresa M. Lavallee Ph.D.No RelationshipsSenior Vice President of Translational Medicine & Product Development49
View More Key Executives

Kolltan Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Arthur G. Altschul Jr. 38 RelationshipsKolltan Pharmaceuticals, Inc.50
Gerald McMahon Ph.D. 28 RelationshipsKolltan Pharmaceuticals, Inc.60
Axel Bolte M.Sc., M.B.A. 33 RelationshipsHBM Partners Ltd.43
Joseph P. Schlessinger Ph.D. 72 RelationshipsKolltan Pharmaceuticals, Inc.70
K. Peter Hirth Ph.D. 94 RelationshipsTrovaGene, Inc.63
View All Board Members

Kolltan Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.Joseph P. Schlessinger72 Relationships7 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$400.0K
Compensation as of Fiscal Year 2013
Kolltan Pharmaceuticals, Inc. CEO Compensation
Industry Average


Kimberly-Clark Announces Board Changes
October 07, 2015 5:12 PM ET
Suominen Corporation Appoints Ernesto Levy as Senior Vice President, Convenience Business Area and Member of the Corporate Executive Team, Effective October 20, 2015
October 06, 2015 6:30 AM ET
SC Johnson Appoints Ann Mukherjee as Global Chief Marketing Officer
October 02, 2015 12:00 AM ET
Spectrum Brands Holdings, Inc. Announces Changes to the Board of Directors
September 28, 2015 12:00 PM ET
Mary Agnes Wilderotter Does Not Stand for Re-Election to Board of Directors of The Procter & Gamble Company
September 25, 2015 8:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Kolltan Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at